Amprenavir

（重定向自Agenerase）

HIV-1 protease dimer with amprenavir (sticks) bound in the active site. PDB entry 3nu3[2]

Amprenavir (original brand name Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours. The convenient dosing came at a price, as the dose required is 1,200 mg, delivered in 8 (eight) very large 150 mg gel capsules or 24 (twenty-four) 50 mg gel capsules twice daily.

单词	Agenerase
释义	Agenerase 英语百科 Amprenavir （重定向自Agenerase） Amprenavir (original brand name Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours. The convenient dosing came at a price, as the dose required is 1,200 mg, delivered in 8 (eight) very large 150 mg gel capsules or 24 (twenty-four) 50 mg gel capsules twice daily.
随便看	block mark block Markov encoding block masonry block mass block mast block mat block matching block matching motion compensation block material block material flow diagram Block matrix block matrix factorization block measure block message block meter rate block method block method of hull construction block mica blockmilk block milk block mill block mining block mining system block mkoraine block mode